Literature DB >> 6714271

Nifedipine serum concentration; effects upon blood pressure and heart rate in normotensive volunteers.

T Nakashima, M Inoki, Y Nakanishi.   

Abstract

Nifedipine (10 mg) was administered orally to 8 normotensive volunteers. Various measurements such as concentration in serum, blood pressure, and heart rate, were made at 0, 20', 40', 1, 2, 3, 4, 6, 8 and 24 h after administration. The sample serum, internal standard (diethyl 2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate), HCl and NaNO2 were allowed to react and GLC-ECD was carried out after extration with organic solvent. The retention time was 3 min for nifedipine and 4 min for internal standard. Absorption curves were classified into 3 types: a rapid absorption rate (2 subjects) in which the maximum measured nifedipine concentration (70-80 ng/ml) was obtained, within 20-40 min after administration, a slower absorption rate (3 subjects) and an intermediate absorption rate (3 subjects) and an intermediate absorption rate (3 subjects). A decrease in systolic blood pressure was observed, but no significant difference in diastolic blood pressure and heart rate could be noted among the volunteers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6714271     DOI: 10.1007/BF03189607

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  15 in total

1.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

2.  [Fluorometric determination of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester and its main metabolite].

Authors:  K Schlossmann
Journal:  Arzneimittelforschung       Date:  1972-01

3.  [Structural analysis of the renal excretion products of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].

Authors:  H Medenwald; K Schlossmann; C Wünsche
Journal:  Arzneimittelforschung       Date:  1972-01

4.  [Dihydropyridines, a new group of strongly effective coronary therapeutic agents].

Authors:  F Bossert; W Vater
Journal:  Naturwissenschaften       Date:  1971-11

5.  Comparison of acute effects of nifedipine in normotensive and hypertensive man.

Authors:  O Lederballe Pedersen; N J Christensen; K D Rämsch
Journal:  J Cardiovasc Pharmacol       Date:  1980 Jul-Aug       Impact factor: 3.105

6.  Gas chromatographic determination of nifedipine and one of its metabolites using electron capture detection.

Authors:  P Jakobsen; O Lederballe Pedersen; E Mikkelsen
Journal:  J Chromatogr       Date:  1979-01-01

7.  Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension.

Authors:  M Thibonnier; F Bonnet; P Corvol
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

8.  Identification of nifedipine metabolites and their determination by gas chromatography.

Authors:  S Kondo; A Kuchiki; K Yamamoto; K Akimoto; K Takahashi; N Awata; I Sugimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980-01       Impact factor: 1.645

9.  Acute and chronic effects of nifedipine in arterial hypertension.

Authors:  O L Pedersen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

10.  Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors:  M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

View more
  1 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.